KRISTEN HAUN: Open Payments
NPI 1053828871 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,781 in 180 payments from 15 companies in 2025. Trend: 2023 $4,149 · 2024 $4,033 · 2025 $3,781
Food & beverage: $3,781
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $1,005 |
| Amgen Inc. | 50 | $681 |
| UCB, Inc. | 23 | $549 |
| PFIZER INC. | 18 | $407 |
| AstraZeneca Pharmaceuticals LP | 18 | $406 |
| Novartis Pharmaceuticals Corporation | 9 | $187 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $160 |
| Mallinckrodt Hospital Products Inc. | 3 | $112 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| Janssen Biotech, Inc. | 5 | $80 |
Products named: RINVOQ, Bimzelx, SAPHNELO, ENBREL, SKYRIZI, XELJANZ, COSENTYX, KRYSTEXXA.
Industry payments across OK — which companies pay providers there.
